Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
(Approval lapsed 31/12/2022) OPTIRAY 320 Ioversol 678mg/mL (equivalent to 320 mg of organically bound iodine) sterile solution for injection 100 mL prefilled syringe (Canada)
Section 19A approved medicine
(Approval lapsed 31/12/2022) OPTIRAY 320 Ioversol 678mg/mL (equivalent to 320 mg of organically bound iodine) sterile solution for injection 100 mL prefilled syringe (Canada)
Section 19A approval holder
Guerbet Australia Pty Ltd ABN: 15 159 798 302
Approved until
Status
Lapsed
Medicines in short supply/unavailable
non - ionic CONTRAST MEDIA SHORTAGE
Indication(s)
Optiray is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. These include cerebral, coronary, peripheral,visceral and renal arteriography, aortography, left ventriculography and venography. OPTIRAY may be used for intravenous excretory urography.
OPTIRAY 320 is indicated in children (excluding neonates) for angiocardiography, contrast enhanced computed tomographic imaging of the head and body, and intravenous excretory urography.
Images
